Ropes & Gray Advises Longview Acquisition Corp. II in SPAC Merger with HeartFlow Holdings

Ropes & Gray represented Longview Acquisition Corp. II, a special purpose acquisition company sponsored by affiliates of Glenview Capital Management, LLC, in a merger with HeartFlow Holdings that will support HeartFlow’s goal of revolutionizing precision heart care. Upon completion of the proposed transaction, the combined company will operate as HeartFlow Group, Inc. and is expected to be listed on the New York Stock Exchange under the symbol “HFLO.” The transaction, announced on July 15, will provide the combined company with an estimated $400 million in cash for growth capital, product development and general corporate purposes.

HeartFlow’s non-invasive artificial intelligence-enabled software is designed to create a personalized three-dimensional model of the heart. By using this model, clinicians can better evaluate the impact a blockage has on blood flow and determine the best treatment for patients. HeartFlow has regulatory clearance and is commercially available today in the U.S., the EU, the U.K. and Japan. 

The Ropes & Gray team was led by private equity and M&A partner Carl Marcellino and associate Jessica Cooney (both of New York) and included capital markets partner Chris Capuzzi (New York), IP transactions and technology partner Regina Sam Penti (Boston), life sciences regulatory & compliance partner Kellie Combs (Washington, D.C.), capital markets partner Paul Tropp (New York), benefits & employment partners Renata Ferrari and Loretta Richard (both of Boston), health care partner Michael Lampert (Boston), data, privacy & cybersecurity partner Ed McNicholas (Washington, D.C.) and tax partner Elaine Murphy (Boston).